Search Results - "Kan, Weijuan"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Inner nuclear membrane protein TMEM201 promotes breast cancer metastasis by positive regulating TGFβ signaling by Kong, Ya, Zhang, Yutian, Wang, Hanlin, Kan, Weijuan, Guo, Haoran, Liu, Yun, Zang, Yi, Li, Jia

    Published in Oncogene (28-01-2022)
    “…Emerging evidence shows the association between nuclear envelope and tumor progression, however, the functional contributions of specific constituents of the…”
    Get full text
    Journal Article
  2. 2

    Structure–Activity Relationship Study of Indolin-5-yl-cyclopropanamine Derivatives as Selective Lysine Specific Demethylase 1 (LSD1) Inhibitors by Li, Chunpu, Su, Mingbo, Zhu, Wei, Kan, Weijuan, Ge, Tianpeng, Xu, Gaoya, Wang, Shuni, Sheng, Li, Gao, Feng, Ye, Yunfei, Wang, Jiang, Zhou, Yubo, Li, Jia, Liu, Hong

    Published in Journal of medicinal chemistry (10-03-2022)
    “…LSD1 is identified as an essential drug target, which is closely correlated to the development of several tumor types. In this work, on the basis of…”
    Get full text
    Journal Article
  3. 3

    Targeting C/EBPα overcomes primary resistance and improves the efficacy of FLT3 inhibitors in acute myeloid leukaemia by Wang, Hanlin, Luo, Guanghao, Hu, Xiaobei, Xu, Gaoya, Wang, Tao, Liu, Minmin, Qiu, Xiaohui, Li, Jianan, Fu, Jingfeng, Feng, Bo, Tu, Yutong, Kan, Weijuan, Wang, Chang, Xu, Ran, Zhou, Yubo, Yang, Jianmin, Li, Jia

    Published in Nature communications (05-04-2023)
    “…The outcomes of FLT3-ITD acute myeloid leukaemia (AML) have been improved since the approval of FLT3 inhibitors (FLT3i). However, approximately 30-50% of…”
    Get full text
    Journal Article
  4. 4

    Phosphorylation of PHF2 by AMPK releases the repressive H3K9me2 and inhibits cancer metastasis by Dong, Ying, Hu, Hao, Zhang, Xuan, Zhang, Yunkai, Sun, Xin, Wang, Hanlin, Kan, Weijuan, Tan, Min-jia, Shi, Hong, Zang, Yi, Li, Jia

    Published in Signal transduction and targeted therapy (06-03-2023)
    “…Epithelial to mesenchymal transition (EMT) plays a crucial role in cancer metastasis, accompanied with vast epigenetic changes. AMP-activated protein kinase…”
    Get full text
    Journal Article
  5. 5

    Targeted Near-Infrared Fluorescence Imaging of Liver Cancer using Dual-Peptide-Functionalized Albumin Particles by Dou, Wei-Tao, Guo, Chen, Zhu, Ling, Qiu, Peng, Kan, Weijuan, Pan, Yu-Fei, Zang, Yi, Dong, Li-Wei, Li, Jia, Tan, Ye-Xiong, Wang, Hong-Yang, He, Xiao-Peng

    Published in Chemical & biomedical imaging (22-01-2024)
    “…Fluorescence imaging is an emerging strategy for preoperative diagnosis and intraoperative resection. In particular, owing to their outstanding spatial…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Exploratory research on the effective chemical basis of tanreqing injection for treating acute lung injury: In vivo, in vitro and in silico by Tang, Bixi, Xie, Like, Wang, Yangyang, Shi, Yulong, Kan, Weijuan, Feng, Bo, Lin, Chenxuan, Xu, Zhijian, Zhu, Weiliang, Li, Jia, Zhang, Xuemei, Tian, Xiaoting, Zang, Yi

    Published in Journal of ethnopharmacology (30-01-2025)
    “…Sepsis-induced acute lung injury (ALI) presents with significant morbidity and mortality in clinical settings. Tanreqing Injection (TRQI) has been clinically…”
    Get full text
    Journal Article
  8. 8

    Discovery of Potent and Selective CDK9 Degraders for Targeting Transcription Regulation in Triple-Negative Breast Cancer by Wei, Dan, Wang, Hanlin, Zeng, Qinghe, Wang, Wenjing, Hao, Bingbing, Feng, Xule, Wang, Peipei, Song, Ning, Kan, Weijuan, Huang, Guifang, Zhou, Xiaoyu, Tan, Minjia, Zhou, Yubo, Huang, Ruimin, Li, Jia, Chen, Xiao-Hua

    Published in Journal of medicinal chemistry (14-10-2021)
    “…Triple-negative breast cancer (TNBC) is highly aggressive with very limited treatment options due to the lack of efficient targeted therapies and thus still…”
    Get full text
    Journal Article
  9. 9

    Design and development of a series of 4-(piperazin-1-yl)pyrimidines as irreversible menin inhibitors by Luo, Menglan, Ye, Yunfei, Tang, Lu, Kan, Weijuan, Chen, Lin, Li, Cong, Sheng, Li, Zhou, Yubo, Li, Jia, Xiong, Bing, Wang, Hanlin, Chen, Danqi

    Published in European journal of medicinal chemistry (15-12-2024)
    “…The interaction between menin and MLL1 protein plays an important role in AML with MLL rearrangement and NPM1 mutation. Blocking the formation of menin-MLL…”
    Get full text
    Journal Article
  10. 10

    Design, synthesis and biological evaluation of thioether-containing lenalidomide and pomalidomide derivatives with anti-multiple myeloma activity by Wang, Yuhong, Mi, Tian, Li, Yiming, Kan, Weijuan, Xu, Gaoya, Li, Jingya, Zhou, Yubo, Li, Jia, Jiang, Xuefeng

    Published in European journal of medicinal chemistry (01-01-2021)
    “…Lenalidomide and its analogs are well-known for treating multiple myeloma. In this work, designed sulfide-modified lenalidomide and pomalidomide were…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Discovery of a Highly Potent, Selective and Efficacious USP7 Degrader for the Treatment of Acute Lymphoblastic Leukemia by Xu, Miaomiao, Fu, Jingfeng, Pei, Yuan, Li, Mengna, Kan, Weijuan, Yan, Ruyu, Xia, Chaoyue, Ma, Jingkun, Wang, Peipei, Zhang, Yan, Gao, Yue, Yang, Yaxi, Zhou, Yubo, Li, Jia, Zhou, Bing

    Published in Journal of medicinal chemistry (08-08-2024)
    “…USP7 is an attractive therapeutic target for cancers, especially for acute lymphoblastic leukemia (ALL) with wild-type p53. Herein, we report the discovery of…”
    Get full text
    Journal Article
  16. 16

    Rational Design and Development of Novel CDK9 Inhibitors for the Treatment of Acute Myeloid Leukemia by Han, Xu, Song, Ning, Saidahmatov, Abdusaid, Wang, Peipei, Wang, Yong, Hu, Xiaobei, Kan, Weijuan, Zhu, Wei, Gao, Lixin, Zeng, Mingjie, Wang, Yujie, Li, Chunpu, Li, Jia, Liu, Hong, Zhou, Yubo, Wang, Jiang

    Published in Journal of medicinal chemistry (14-10-2021)
    “…CDK9 is an essential drug target correlated to the development of acute myeloid leukemia (AML). Starting from the hit compound 10, which was discovered through…”
    Get full text
    Journal Article
  17. 17

    Ardisiphenol D, a resorcinol derivative identified from Ardisia brevicaulis, exerts antitumor effect through inducing apoptosis in human non-small-cell lung cancer A549 cells by Zhao, Feng, Hu, Yuan, Chong, Chuanke, Lu, Minghui, Chen, Liping, Kan, Weijuan, Chen, Lei, Liu, Hongwei

    Published in Pharmaceutical biology (01-07-2014)
    “…The in vitro and in vivo antitumor activities of ardisiphenol D, a natural product isolated from the roots of Ardisa brevicaulis Diels (Myrsinaceae), have been…”
    Get more information
    Journal Article